OLS OMNI Life Science and Namocell sign distribution agreement
Single cell sorting and dispensing instruments now available in Germany and Austria
Unsplash
“There has been significant demand for our Single Cell Dispensers in Germany and Austria,” said Namocell CEO Dr. Junyu Lin. OLS as a leading player in the Germany and Austria markets with strong track record in distributing cell-based research is a perfect partner to serve the markets.
“Namocell’s industry-leading single cell isolation instruments are a game-changer for cell line engineering and development, CRISPR, single cell genomics, antibody development and other single cell applications. The Namocell Single Cell Dispenser is fast, gentle and very easy to use. It enables researchers to sort and dispense single cells within minutes while preserving cell viability and integrity, so you can get excellent outgrowth and better data. It can handle sample input ranging from 100 cells to 150 million cells/mL. The versatility offers an ideal solution no matter you have precious clinical samples or want to isolate extremely rare cells from a large amount of cells,” said Dr. Andreas Friese, OLS Director Sales & Marketing. “We are very excited to bring these innovative high-performance instruments to more labs in Germany and Austria.”
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.